Probing the mechanism of reduced in vivo potency of insulin detemir.

Published in: Expert opinion on drug metabolism & toxicology (2023)

A large proportion of NRMD of IDet which can be inhibited by bacitracin may partly explain the reduced potency of IDet observed in rats and likely also in man.

Keyphrases

type diabetes
single molecule
molecular dynamics simulations
weight loss